Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Director departure
Appointed director
CorMedix Inc. (CRMD) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/08/2023 8-K Quarterly results
Docs: "CorMedix Inc. Reports SECOND Quarter AND SIX MONTH 2023 Financial Results and Provides Business Update"
06/30/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNDERWRITING AGREEMENT DATED JUNE 28, 2023",
"FORM OF PRE-FUNDED WARRANT",
"OPINION OF MORGAN, LEWIS & BOCKIUS LLP",
"CORMEDIX INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS Berkeley Heights, NJ – June 28, 2023 – CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced that it intends to offer and sell shares of its common stock, and in lieu of common stock to certain investors that so chose, pre-funded warrants to purchase shares of its common stock, in an underwritten public offering. All of the shares and pre-funded warrants to be sold in the offering will be offered by CorMedix. In addition, CorMedix intends to grant the underwriters a 30-day option to purchase up to an additional 15% of shares of its common stock offered in th..."
05/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact:"
04/26/2023 8-K Quarterly results
04/17/2023 8-K Quarterly results
03/30/2023 8-K Quarterly results
03/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "CORMEDIX INC. ANNOUNCES REGULATORY AND MANUFACTURING UPDATES"
11/10/2022 8-K Quarterly results
10/21/2022 8-K Quarterly results
10/17/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/11/2022 8-K Quarterly results
08/09/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
03/29/2022 8-K Quarterly results
Docs: "+++++++++ 3 CORMEDIX INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS"
03/28/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "+++++++++"
03/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Award Agreement INCENTIVE stock option AWARD AGREEMENT",
"+++++++++"
02/28/2022 8-K Quarterly results
12/23/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EXECUTIVE BONUS PLAN",
"FORM OF BONUS GRANT LETTER"
12/13/2021 8-K Quarterly results
11/09/2021 8-K Quarterly results
Docs: "+++++++++ CORMEDIX INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS"
10/29/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter Agreement, dated and effective October 26, 2021, between CorMedix Inc. and Matthew David, M.D"
09/07/2021 8-K Quarterly results
08/12/2021 8-K Quarterly results
Docs: "+++++++++ CorMedix Inc. and SubsidiarIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS For the Three Months Ended June 30, For the Six Months Ended June 30, 2021 2020 2021 2020 Revenue: Net sales $ 8,191 $ 16,443 $ 96,451 $ 90,498 Cost of sales Gross profit 20,686 22,797 Operating Expenses: Research and development Selling, general and administrative Total Operating Expenses Loss From Operations Other Income : Interest income 3,340 38,603 7,014 102,282 Foreign exchange transaction gain Interest expense, including amortization of debt discount - Total Other Income 22,972 Loss before income taxes Tax benefit 1,250,186 5,169,395 1,250,186 5,169,395 Net Loss Other Comprehensive Income : Unrealized gain from investments 13,853 8,221 Foreign currency ..."
05/13/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
04/15/2021 8-K Quarterly results
03/30/2021 8-K Quarterly results
03/12/2021 8-K Quarterly results
03/01/2021 8-K Quarterly results
01/21/2021 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
Docs: "+++++++++"
12/18/2020 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
11/27/2020 8-K Quarterly results
11/18/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "+++++++++"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy